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11. INTRODUCTION 
The intimate relationships between societies and ecosystems have, throughout 
history, given rise to complex challenges to human health (Ranger and Slack, 
1996). McNeil (1977), for instance, documents how health problems have co-
evolved with ecological dynamics associated with different forms of human 
settlement, available technologies and livelihood strategies. He argues that the 
burden of parasitic and infectious diseases grew as people lived in closer proxim-
ity with a small number of other species. He also relates the major pandemics of 
the plague several centuries ago to changing patterns of global trade. Diamond 
(1998) argues that human coexistence with potential pathogens is central to 
understanding the divergent development paths of the continents. The devel-
opment of institutions and governance arrangements to help people and soci-
eties cope with sickness similarly has a long historical provenance (Porter 1997). 
They characteristically include rules of behaviour to improve public health and 
arrangements for generating and making available specialised medical knowl-
edge. Diamond (2006) documents the devastating impact on society of an in-
ability to respond adequately to health-related challenges.
Such historical analyses underline several things. First, whether at global, conti-
nental or local scales, health is central to sustainability: major health problems 
can dramatically damage societies and economies and their durability and 
resilience over time. Second, the dynamics of human health - and the disease 
ecology that influences it - are intimately entwined with social, technologi-
cal and environmental change. Third, whether the pathways that unfold lead 
to sustainability or otherwise, depends very much on institutions, power and 
knowledge. These concerns with pathways to sustainability - and especially 
their implications for the wellbeing of poorer people living in developing and 
transitional economies - are central to the newly established STEPS Centre at 
Sussex. 
Global health systems are reaching a turning point. Health is rising up the politi-
cal agenda in many countries. In regions experiencing rapid economic growth, 
this is associated with the rise in age-related health problems, changing ex-
2pectations linked to economic growth and the development of the media, the 
emergence of new epidemic diseases and the spread of markets for medical 
goods and services. Elsewhere, the response to HIV and AIDS has attracted 
increasing political attention, although the cost of treating chronic diseases 
is also becoming a concern. The public and the political elite in rich countries 
have become increasingly interested in the health problems of poor countries 
and possible threats to global wellbeing. Science increasingly promises solu-
tions to health problems through new drugs, vaccines and other technologies. 
Governments and private foundations have committed a lot of money and 
these commitments could grow. This is creating big opportunities for improving 
the lives of poor people. It is also creating risks that measures taken by the rich 
and powerful to protect themselves could damage the wellbeing of the poor. 
For example political pressure by citizens of rich countries for protection from 
perceived risks of epidemics may divert attention and resources from interven-
tions aimed at addressing the immediate problems of the poor.
This working paper aims to stimulate thought about how to make the best use 
of these opportunities and reduce the risks. It brings together thinking from 
several disciplines relevant to understanding the dynamics of human health 
and the institutions and governance arrangements for organising responses to 
disease. It suggests some concepts and approaches helpful for understanding 
these, linking to those laid out in more detail in other papers in this series (see 
especially STEPS Centre Working Papers 1, 2 and 3 on Dynamics, Governance 
and Designs). It proposes elements of a research agenda to address emerging 
health challenges in today’s rapidly changing world.  
The context of rapid change, in both the ecology of human disease and the use 
of specialised knowledge to influence this ecology, is central to the discussion. 
Human ecology has been changing very quickly since the onset of the industrial 
revolution and the rate of change has accelerated during the past half century. 
This has contributed to the emergence of major health challenges, such as the 
introduction of HIV to the ecosystem, pollution-related disasters and the fear 
of a pandemic of Avian Influenza. We are likely to experience more such chal-
lenges. The numbers of humans and domestic animals are increasing rapidly.1 
A growing proportion lives in densely populated localities and under livelihood 
1 They are projected to reach 6.5 billion humans, 1.3 billion cattle, 1.1 billion sheep and 1.0 billion 
pigs by the turn of the 21st Century. A large proportion of the people who have ever lived are alive 
today. One understanding of a species’ biological history is in terms of numbers of individuals, 
episodes of reproduction and interactions between that species and others. From that point of 
view, a substantial proportion of human biological history is taking place now and the number of 
potentially major health challenges per period of time is likely to grow.
3conditions that have major consequences for interactions with potential patho-
genic organisms. Some developments in technology and social organisation 
have greatly enhanced the capacity of humans to live healthy lives, but others 
have introduced stressors, including chemicals and particulate pollutants, to 
ecosystems. Social and technological changes have increased the volume and 
speed of travel, providing new mechanisms for the rapid spread of pathogenic 
organisms and environmental stressors. We are at an early stage in the manage-
ment of the potential health consequences of rapid ecological change (Brownlie 
et al 2006). 
At the same time - and especially since the mid-20th Century - knowledge and 
the capacity to apply it towards the achievement of human purposes has devel-
oped rapidly.2 This includes diverse strands in the systematic study of the world 
that constitutes scientific knowledge, as well as the multiple ideas and ways 
of knowing that constitute popular or lay knowledge. We have new technolo-
gies and new types of organisation that enable complex divisions of labour in 
increasingly sophisticated medical care systems. The effective use of relevant 
knowledge to address health problems has made an important contribution 
to the quality of many people’s lives. For instance, the development of public 
health was instrumental in making possible the successful urbanisation that 
began in the 19th Century and scientific advances provide effective responses 
to many health problems. Developments in a number of scientific disciplines 
suggest many future possibilities for reducing suffering and prolonging human 
life. These same changes have also been associated with the emergence of new 
patterns of social inequality and new forms of poverty. 
This paper is intended to complement a body of work that documents the 
burden of disease and projects morbidity and mortality trends (Mathers and 
Loncar 2006; Mathers et al 2006). It focuses on the uncertainty associated with 
dynamic and complex systems and different ways of understanding or ‘framing’ 
these, and the special challenges this presents to individuals and societies in 
dealing with rapid change. Its aim is to stimulate debate about the forms of 
knowledge and governance arrangements for dealing with health challenges 
appropriate for shaping pathways to sustainability that meet the needs and pri-
orities of specific groups of poorer people. 
2 A very high proportion of all written work in the history of humanity has been written by 
someone alive today.
4In section 2, we suggest that a variety of factors during the mid to late-20th 
Century led to a widespread belief in the inevitability of both economic and 
technological development and continuing health improvements. This was 
grounded in a broad set of assumptions about relative stability (ie gradual and 
predictable change over time) in socio-political, ecological and technological 
systems. Most projections of future developments are still based on this kind of 
assumption.
In section 3, we explore emerging evidence, as well as new understandings, of 
the co-evolving nature of human-disease-ecology-technology dynamics. These 
raise challenges for addressing health problems in a sustainable manner, and 
meeting the needs of poorer and marginalised people. They show why assump-
tions about stability and inevitable progress can make health interventions 
dangerously unsustainable, for instance as ecology ‘bites back’ in treatment-
resistant infectious organisms, or as poorer people find themselves caught in 
low productivity, low health status vicious circles. 
Section 4 explores how the realities of health institutional and governance ar-
rangements are unfolding, and how governance arrangements are shaped by 
and in turn shape systems dynamics. They reveal new complexities in the inter-
actions between multiple actors across scales, and in the politics of knowledge. 
Some of these emerging arrangements are responses to perceived inadequa-
cies of existing approaches. The section outlines some recent bodies of work 
that contribute to an understanding of emerging governance realities.
Major challenges remain in understanding and working to influence the relation-
ships between social-ecological-technological dynamics, and governance - in 
other words, integrating the insights that sections 3 and 4 review. This involves 
the resolution of a number of tensions: (i) between the benefits from knowledge 
and technologies based on simplifying and universalising assumptions and the 
uncertainty associated with rapidly changing and complex realities; (ii) between 
the increasing capacity for innovation and the need for stable rules and norms 
to organise coherent responses to challenges; and (iii) between the potential 
for rapid response and the risk of greater uncertainty and instability due to the 
growth in the number of people involved in producing, accessing and applying 
diverse forms of health-related knowledge. This third tension speaks also to the 
diverse ways in which different people and groups may frame, understand and 
prioritise health-related goals. In this context, it is insufficient to speak simply 
of sustainability of social-ecological-technological systems in relation to health 
in general terms. We also need to acknowledge Sustainability, or the particular 
dimensions of health, wellbeing and related system properties valued by par-
5ticular groups (see STEPS Working Paper 1 on Dynamics), and the contestation 
over priorities that these can entail. 
It is impossible to draw together all knowledge relevant to an understanding of a 
rapidly changing reality. Responses based on past experience and accumulated 
scientific knowledge are often highly efficacious, but they can miss new reali-
ties, complex, long term, impacts, and conflicts with the experiences and goals 
of particular people. Thus it is important to take into account knowledge and 
understandings - or framings - of health problems from multiple viewpoints, and 
to appreciate how each may be linked with particular interests and power rela-
tions. The major challenge for the health work of the STEPS Centre is to identify 
approaches for responding to health challenges that take into account the 
importance of science and social science to the design of effective responses 
to health challenges, while acknowledging the reality of complex and dynamic 
systems. This involves a willingness to acknowledge uncertainty, multiple 
framings, and the influence of power relationships. It is in this light that the con-
clusion reflects on key elements of a research approach and agenda.
2. THE ILLUSION OF INEVITABLE PROGRESS AND STABLE 
HEALTH SYSTEMS
Contemporary health systems developed in response to the challenges and 
crises noted at the beginning of this paper. For a relatively brief period during 
the second half of the 20th Century, a set of beliefs about how to understand 
and deal with health problems dominated, based on optimistic expectations 
about the inevitability of both economic growth and health improvement. 
These beliefs have become unsettled, but continue to influence thinking about 
health systems. This is one reason, for example, why it has been so difficult to 
formulate an effective global strategy for meeting the challenge of HIV (Barnett 
and Whiteside 2002).
Concerns with public health were central to the building of nation states in 18th 
and 19th century Europe (Anderson and May 1991). During the early period of in-
dustrialisation and urbanisation, many societies experienced social disorder and 
major health problems (Szreter 1997; Szreter and Mooney1998). In addition to 
upsurges of civil conflict and periodic epidemics of infectious disease, there was 
a fear of deteriorating health and breakdown of previous social relations, particu-
6larly in the localities experiencing rapid change. Writings of the period reflect the 
mid-19th Century anxiety that the new social order might be unviable in the face 
of major health problems such as cholera (Engels 1845 Virchow 1879; Williams 
1987). Responses to these crises contributed to the creation of modern nation 
states with their many social responsibilities, including public health, and to the 
development of a number of scientific disciplines.
Emergent understandings of disease-population relationships, together with 
record-keeping, statistics and the application of probability theory to modelling 
aggregate behaviour, formed the basis for new state institutions and policies 
(Hacking 1983). For instance, national public health systems were put in place in 
Europe following epidemics of water-borne disease in rapidly urbanising areas 
(Porter 1999; Evans 1990). Foucault (1978), and many others, have pointed out 
the impossibility of separating the scientific framing of many social problems 
from issues of control in contexts of inequality in access to economic goods and 
political power. This is particularly evident with the spread of scientific and asso-
ciated managerial approaches into the developing world through imperial and 
colonial interventions in public health (Doyal 1979; Arnold 1988; Vaughan 1991, 
White 2000; Yeoh 2003). These often articulated uneasily with diverse local 
forms of knowledge and practice. They rested heavily on the nascent sciences 
of epidemiology and public health, concerned with understanding health at an 
aggregate population level. Interventions largely reflected the needs of settlers 
and the colonial elites.
By the end of the 19th Century, existential fears of uncontrolled epidemics had 
subsided and public health systems were well-established. Many of the diseases 
that had threatened the security of Europe during the mid-19th Century were 
redefined as ‘tropical’ and newly established institutes of tropical medicine were 
assigned the task of generating knowledge about them. European institutes 
were funded as part of the colonial enterprise, while in the United States, large 
charitable foundations were an important source of finance. Christian churches 
and medical missions played an important role in the provision of medical care 
in many countries. The control of these diseases was associated with major 
development enterprises and with military security. The dominant discourse 
increasingly understood health and disease to be part of a set of biological or 
‘natural’ processes, separate from the socio-political - with the latter assumed 
to be able to control the former. Of course, there was a persistent counter-dis-
course amongst social reformers, revolutionaries and anti-colonial intellectuals.3
3 Doyal 1979 and Navarro 1982 provide useful summaries of the major arguments from this 
critical tradition.
7The basic structure of the modern health sector was established and consoli-
dated during the wave of globalisation and colonisation that was disrupted by 
the outbreak of the First World War. The institutional arrangements4 were based 
on the nation state in a small number of economically powerful countries. They 
created complex health systems involving government, regulatory agencies, 
the legal system, large corporations, charitable foundations and a variety of non-
governmental, religious and community organisations. These arrangements re-
flected both dominant understandings of public health and medical science and 
prevalent economic and social arrangements (Bloom et al forthcoming).5 The 
health services of colonies reflected both colonial influences and the needs and 
interests of the local state. Characteristically, a highly segmented government 
service provided basic public health for the majority and sophisticated services 
for the privileged elite. These systems gradually broadened their services for the 
majority of the population to include basic medical care provided by paramedi-
cal workers. Some countries also had a regulated private sector that replicated 
regulatory structures from one of the dominant countries. A number of analyses 
have documented how this near-global health system replicated and reinforced 
social inequalities. 6 
In the 20th century, advances in scientific knowledge radically transformed 
people’s abilities to influence the biology of disease. Before the introduction of 
sulphonamide drugs in the mid-1930s, physicians practising what is now called 
conventional or allopathic curative medicine had little to offer patients beyond 
their time, advice and encouragement. While substantial advances had been 
made in related areas such as nutrition, hygiene, disinfectants, antiseptics, vac-
cination and surgery, most diseases were ‘treated’ by attending to the patient’s 
basic needs until they recovered or died (Lewis, 1983).  Just over 30 years later, 
in 1968, the U.S. Surgeon General felt able to proclaim that ‘The war against 
diseases has been won’ (Greger, 2006, p. 85). This euphoric statement was pri-
marily based on the development of antibiotic remedies. It was assumed that 
the widespread use of these ‘magic bullets’, combined with the application of 
4 Such as colleges of medicine and surgery which validate qualifications.
5 There is a long history of debate about the degree to which the governance arrangements that 
emerged reflected functional needs or power relationships in, for example, the emergence of 
self-regulating professions and a pharmaceutical sector combining large private corporations and 
powerful regulatory agencies. Recent analyses of institutional development emphasise the strong 
influence of an institution’s early history on its subsequent development (Pierson 2000; Pierson 
and Skocpol 2002). This has led to an emphasis on the multiple influences on health system 
structure including the role of dominant ideas and understandings.
6 See Doyal 1979; Illiffe 1987; Turshen 1989; Navarro 1992; Marks 1994; Lee and Zwi 2003; Farmer 
2005.
8childhood vaccinations and improved environmental conditions, would steadily 
eliminate the threat from disease. ‘Victories’ or near victories, at least in Europe 
and the US and in some cases in the developing world, against measles, diph-
theria, pertussis, tetanus, malaria, polio and smallpox, strongly reinforced this 
perception. At its heart lay an essentially static framing of the interrelationship 
between humans and disease, which assumed the existence of a ‘fixed set’ of 
diseases that medical science would sequentially eradicate.
In the 1960s and 1970s many ex-colonies and post revolutionary societ-
ies became strongly committed to the reform of their highly unequal health 
systems through the provision of universal access to health care. These com-
mitments were a response to popular demands articulated within political 
movements and were based on a belief that people had been denied access 
to effective technologies for improving their health. The 1930s experience of 
the Soviet Union in creating a state-run public health system influenced these 
strategies. The basic assumption was that governments should lead efforts to 
overcome major shortages in the number of facilities and health workers and 
in the availability of pharmaceuticals and other health-related commodities. In 
many countries government became a monopoly supplier of organised health 
services, managed through a command and control bureaucracy. The assump-
tion was of relatively homogeneous and stable needs across nation states, even 
globally - so that standard delivery models (as well as standard technologies) 
could be rolled out. This was consistent with a broad development approach 
that focused on overcoming major shortages in human, physical and financial 
resources.  The international community endorsed these views in the Alma Ata 
Declaration (WHO 1978) and the so-called Health For All Strategies of the WHO 
(Kickbusch 2003). This approach was associated with dramatic improvements 
in health indicators in many countries, including some of the poorest.
The longer term outcome of these health development strategies has been 
variable. Some countries established highly effective health systems but others 
failed to do so. A large range of interventions has been effective, but others have 
failed, proved unsustainable or been resisted. The broad assumption was, and 
often remains, that stable institutions could be expected to deliver a relatively 
standard set of interventions. Much analysis of failure remains within this vein, 
focusing on specific problems of implementation. Thus for instance problems 
of resource scarcity (financial, physical and human) are highlighted, leading to 
arguments for a combination of revised government priorities and inter-country 
resource transfers to low-income countries (Simms et al 2005; Garrett 2007). 
Equally gaps in the availability of technological solutions are highlighted, with 
progress and investment in new scientific knowledge expected to fill in - as with 
9the search for vaccines against malaria, for instance. The dominant emphasis 
in international health remains on the identification of and then rapid ‘scaling-
up’ and ‘rolling-out’ of such interventions (Commission on Macroeconomics 
and Health 2001).  More fundamentally, however,  health intervention failures 
highlight emergent problems as assumptions about stable institutions and 
standard interventions confront more complex, dynamic and diverse reali-
ties. As they interplay with dynamic social and political systems, for instance, 
problems of accountability have resulted (e.g. Pritchett and Woolcock 2004), 
while power relations have sometimes undermined poorer people’s access to 
resources, livelihoods and wellbeing (Birdsall 1999; Farmer 2005; Lee and Zwi 
2003). Furthermore, as we explore in the next section, health interventions also 
confront highly dynamic human-disease ecological systems, and the varied ex-
periences and framings of these by different social groups. Addressing health 
problems effectively in this dynamic context requires, we suggest, new ways of 
thinking about institutions, governance and the design of interventions. These 
need to be more responsive to such dynamics and the ways they play out in 
diverse settings. 
This brief account has done little justice to the vast literature on the links 
between health, disease and development (Bloom and Sachs 1998; Marmot 
2005; Wilkinson and Pickett 2006). Its aim has been to draw out how much 
of the debate has been based on assumptions of a relatively stable world, of 
disease as part of biological systems that can be treated as separate from social 
and political processes, of the universal appropriateness of dominant biomedi-
cal models, of steady technological and economic progress, and of institutional 
arrangements for health service delivery that can easily be transferred from one 
context to another.  
This optimistic view is increasingly contradicted by experience. These include 
both specific health intervention and system failures, as well as major reversals 
in health status and life expectancy in some countries in Africa and the former 
Soviet Union. These have punctured the comfortable assumption that problems 
of illness will inevitably diminish. Households, communities and entire societies 
can become caught in vicious circles of health-related impoverishment. It has 
become clear that gains in health are fragile, depending on a wide variety of 
factors. Addressing the dynamic ways these interact is a central task, to which 
the next section turns.
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3. HEALTH AMIDST DYNAMIC SYSTEMS 
The evolution of pathogens and their interaction with bodily processes, tech-
nologies, and socio-political and demographic change is often highly interde-
pendent, non-linear, and context-specific. This points to the need for a more 
complex and dynamic perspective on human-disease-ecological systems. This 
needs to take seriously the possibility that different people and groups frame 
and experience system dynamics in different ways; that dynamics involve 
inherent uncertainty, and that processes and their effects often operate over 
overlapping temporal and spatial scales. These issues and arguments are elabo-
rated more fully in STEPS Working Paper 1 on Dynamics. This section develops 
and illustrates key aspects in relation to health through sub-sections that move 
from a focus on the dynamics of disease and disease-population interactions, to 
perspectives that link disease ecology with interacting ecological and socio-po-
litical dynamics, illustrated from industrial as well as rural contexts, to a consid-
eration of the impact of shocks and stresses. These emphasise the importance 
of systems properties such as resilience, leading into a discussion of challenges 
for Sustainability.
THE EVOLUTIONARY DYNAMICS OF PATHOGENS
A first challenge to linear views of the relationship between human and disease 
ecology comes from evidence of the capacity of pathogens for very rapid 
evolution. It is several decades since Francis Crick originated the often quoted 
‘Orgel’s Second Rule’ (Dennett 1995), named after a colleague, which states that 
“Evolution is cleverer than you are”. In the present context it expresses the fact 
that the evolutionary ‘trial and error’ approach of pathogens will typically defeat 
the most carefully thought out human defence strategies. Evolution is also 
giving rise to entirely new human pathogens, typically by the process known 
as zoonosis, when non-human viruses cross the species barrier (Woolhouse, 
2002). 
One dynamic framing of human-pathogen relations from an evolutionary per-
spective is provided by Lederberg (1998, p.1):
‘Our relationship to infectious pathogens is part of an evolutionary 
drama. Here we are; here are the bugs. They are looking for food; 
we are their meat. How do we compete? They reproduce so quickly, 
and there are so many of them. … Their numbers, rapid fluctuations, 
and amenability to genetic change give them tools for adaptation 
that far outpace what we can generate on any short-term basis.’ 
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HIV, for example, can generate more than 109 virions per day. Its mutation rate 
is around 10-4 mutations per nucleotide, some 10,000,000 times the rate for 
human DNA. Each affected person hosts a vast and genetically highly diverse 
virus population, posing immense targeting problems for the immune system 
and any conceivable drug treatment. The only reason we are still here, Lederberg 
suggests, is that ‘our microbial adversaries have a shared interest in our survival. 
Truly severe host-pathogen interactions historically have resulted in elimination 
of both species. We are the contingent survivors of such encounters because of 
this shared interest’.
This analysis is somewhat simplistic, to the extent that it discounts human 
attempts to ‘compete’ with pathogens, assigning humanity an essential passive 
role. This sits uneasily with medical advances, such as antibiotics, which allow 
a much more aggressive stance. An alternative approach which takes this into 
account, while accepting the underlying ‘evolutionary drama’, involves the 
extended phenotype concept (Dawkins, 1983), in which an organism and its 
artefacts are treated as an entity in terms of evolutionary processes. Dennett 
(1996) argues that in the case of the human species the extended phenotype 
should include not only physical artefacts – including drugs, antiseptics and 
hospitals – but accumulated human knowledge, which would of course include 
knowledge relating to health. Human beings do not compete with pathogens 
simply as ‘naked apes’ but as a species with a vast array of knowledge-based 
‘weapons’, both defensive and offensive. In the ongoing evolutionary struggle 
with disease each side may hold the temporary advantage but there is no cer-
tainty as to even the medium term outcome.
POPULATION-DISEASE DYNAMICS
Emerging evidence and understandings of the dynamics of disease spread 
within populations provide more nuanced understandings of the development 
of disease in contexts of economic, social and ecological change. Simple math-
ematical models of disease (e.g. Hethcote, 2000) divide populations into three 
groups: the susceptible, the infected and the recovered (the last usually assumed 
to have acquired some degree of immunity). The dynamics of any disease can 
then be specified in terms of: (a) transitions between these states; (b) increases 
in total population size via birth or in-migration; and (c) decreases in population 
size via death (including deaths resulting from the specified disease) and out-
migration. 
12
A ‘successful’ pathogen (in terms of self-replication) will have a high contact 
rate, spreading easily from infected to susceptible individuals, and a long infec-
tion period, avoiding both the early recovery or death of an affected individual. 
The product of the contact rate and infection period is a determining factor in 
terms of the proportion of the population that will be infected. This is known as 
the ‘basic reproductive ratio’ because it can be shown to be equivalent to the 
average number of secondary cases caused by each infectious individual in a 
totally susceptible population. When this ratio is greater than 1, the number of 
cases will increase, whereas when it is less than 1, the disease will always fail to 
spread. Estimates have been made for a variety of diseases, including AIDS (2-5), 
smallpox (3-5), measles (16-18) and malaria (greater than 100). Where the basic 
reproductive ratio is relatively low, such as with smallpox, it is possible to reduce 
the susceptible population below a threshold, which leads to eventual eradica-
tion. This is much more difficult for measles or malaria, where the disease will 
persist even if a relatively small proportion of the population is susceptible. 
The above estimates for the basic reproductive ratio assume that it is indepen-
dent of population size, implying that contact rates in small and large popula-
tions are similar. This framing of the model is based largely on empirical evidence 
from OECD countries and is open to question. The contact rate is often primar-
ily determined by social and cultural factors and cannot be estimated from a 
purely bio-medical perspective. As work in participatory epidemiology argues, 
better understandings of real population-disease interactions require models 
to be geared to real ecologies and social and cultural dynamics. These often 
throw up major qualifications to epidemiological models and their assumptions. 
Recent work, for example, has emphasised the variation in contact rates across 
population members and suggested that the role of ‘super-spreaders’, individu-
als with very high contact rates, has to be understood in order to understand 
the development of many diseases (Lloyd-Smith et al, 2005). A number of 
authors have postulated a high correlation between contact rates and popula-
tion density (Garrett, 1995). They suggest that rapid population growth in urban 
centres, especially in less developed economies, has resulted in overcrowded 
accommodation and highly congested transport systems which, combined 
with inadequate water and sanitation services, provide greatly increased oppor-
tunities for person to person disease transmission. On this basis, the four-fold 
growth in the world population over the last century (fig. 1) is seen as providing 
the “tinder” which will allow a pandemic to “explosively hit world populations 
like a flash flood” (Greger, 2006, p.69). But, whether and how this will happen 
also depend, crucially, on socially and politically-shaped patterns of population 
distribution and living conditions. (Woolhouse, 2003; Brownlie et al, 2006) 
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The impact of population growth interacts with increased population mobility, 
and the socio-economic factors shaping it. Much attention has focused on the 
more than two billion air journeys a year that make the isolation of a disease 
outbreak an increasingly formidable task.7 In some countries internal rural-urban 
migration is equally important. For example, 80-100 million Chinese constitute 
the so-called ‘floating population’, who work in the more prosperous urban 
areas and typically return to their family homes in poor, and possibly relatively 
isolated, rural areas at least once each year to celebrate the Spring Festival. 
While there has been much discussion of disease risks associated with flows 
from poorer to richer locations, for example with the rise in TB in Europe and 
the United States linked to migration from Africa and Asia, flows in the opposite 
direction have been given less attention. During the SARS outbreak of 2003, 
some rural communities in China denied access to anyone from the perceived 
urban centres of the outbreak and a number of African countries restricted 
travellers from Toronto, where a number of cases had been identified.8 These 
precautions responded to the potentially devastating impact of SARS in areas 
which had very limited capacity for identification, containment or treatment of 
the disease.
EMERGENCE AND RE-EMERGENCE OF INFECTIOUS DISEASES
The growth and current size of global populations - of both people and domestic 
animals (see Figures 1 and 2) - can be seen as key factors in terms of the emer-
gence or re-emergence of disease. This is argued to be via a number of related 
but distinct pathways (Brownlie et al, 2006). Two derive from the link between 
population size and the number of individuals infected by a given disease. First, 
the latter is directly related to the probability that new pathogens or new strains 
of existing pathogens will arise via spontaneous genetic mutation within those 
human hosts. This is probably the source, for example, of the nine currently 
identified subtypes of the most common HIV pathogen, the  HIV-1 group M 
virus, and the variety of ‘circulating recombinant forms’ of that virus which are 
regarded as hybrids of the other subtypes (AVERT, 2007). Second, if drugs are 
used to treat such an infected population, the result will typically be induced 
evolution of the pathogens, as strains with greater resistance to those drugs 
tend to predominate. 
7 Source:  http://www.oag.com/oag/website/com/OAG+Data/News/Press+Room/
Press+Releases+2006 /OAG+Review+of+2006+030606
8 Personal observation and communications.
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A third pathway is ‘zoonosis’, the process whereby disease passes to humans 
from other species. The extent to which zoonosis has contributed to recent 
emergent and re-emergent diseases is open to debate, but a relatively recent 
editorial in the Lancet (2004, p.257) states that “all new infectious diseases 
of human beings to emerge in the past 20 years have had an animal source”. 
Given the huge reservoir of known and unknown pathogens in animal species 
it seems extremely likely that the number of such diseases will steadily increase 
(WHO, 2004).
Both wild and domestic species are implicated in zoonosis. The HIV-1 virus is 
assumed to have evolved from a very similar virus found in the wild chimpan-
zee species Pan troglodytes troglodytes (Gao et al.,1999). On the other hand 
“Integrated pig-duck agriculture, an extremely efficient food production system 
traditionally practiced in certain parts of China, puts these two species in contact 
and provides a natural laboratory for making new influenza recombinants” 
(Morse, 1995, p.11). Current concern relating to the H5N1 avian influenza virus 
has focused on the transfer of infection from domestic poultry to humans, but 
it is generally accepted that wild birds are the primary reservoir for the disease 
(Lancet, 2004). One obvious distinguishing characteristic between these two 
potential sources of human infection is that while the wild populations of most 
species (notably mammals, birds and fish) have tended to decline in numbers, 
growth in domestic livestock populations has mirrored that in the human popu-
lations which consume them or their products (Figure 2). 
It is plausible that the links discussed above between human population size 
and the risk of disease emergence and spread apply equally to domestic 
animals. Absolute population size increases the risk of spontaneous mutations. 
Yet as with human-disease interactions, a Malthusian perspective is insufficient 
without taking account of technological and political-economic conditions. For 
instance, the widespread use of antibiotics to prevent cross-infection between 
animals kept in close confines almost certainly promotes the evolution of drug 
resistant strains. The conditions of animal production also influence the likeli-
hood of transmission of infections by keeping animals in close proximity and by 
transporting animals over long distances. 
It is also necessary to consider the potential for an increased contact rate 
between domestic animals and humans. One major international report on 
emerging zoonotic diseases suggests that rapid economic growth and urbani-
sation in Asia, associated with the development of large industrial-type poultry 
and pig production units constitute a major risk factor (WHO, 2004, p. 26). While 
much attention has focused on the implications of intensive, industrialised 
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livestock production methods, it should not be overlooked that small-scale 
producers have also responded to the increased demand for animal products, 
even among the poorest populations. In many countries, chicken farming is 
one of the few income generating activities open to poor women, possibly with 
the aid of a loan from a micro-credit agency. International NGOs have encour-
aged the provision of goats to poverty-stricken households in dryland regions 
where there is limited scope for alternative agricultural activities. Small-scale 
production clearly poses a different but possibly no less compelling series of 
risks and uncertainties in terms of emergent or re-emergent disease. Contact 
between livestock animals, humans, and wild species will typically be substan-
tially higher. 
Proposed links between human population growth and the risk of zoonotic 
disease from wild animal species focus primarily on the environmental impacts 
resulting either from the ‘invasion’ of  areas which have previously been at 
most sparsely inhabited or from radical changes in land use. Perhaps the most 
remarkable illustration of this pattern relates to the emergence of zoonotic 
hemorrhagic fevers over the second half of the 20th century, as rainforests were 
cleared for crop or livestock cultivation in South America (Greger 2006).  Two 
other hemorrhagic fevers are seen as resulting from deforestation and popula-
tion shifts in Africa: Lassa Fever and Rift Valley Fever (Morse, 1995). Here the 
contributing political-economic dynamics have varied from dam construction 
to diamond mining and logging. For instance as roads have been driven into 
isolated and remote areas, increases in population and commercial activity to 
support logging operations have resulted in an upsurge in demand for bushmeat, 
wild animals killed, butchered and sold locally for food. It is now widely believed 
that this practice may have been responsible for the initial transmission of the 
HIV virus to humans and that the transmission of a range of retroviruses is ‘a 
regular phenomenon and a cause for concern’ (Wolfe, 2004, p.932). 
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Figure 1: World population (million) 1890-2000
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Figure 2: World livestock numbers: Cattle, Goats, Pigs, Sheep (million) and 
Chickens (10 million) 1890-2000
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HEALTH AND ECOLOGICAL-SOCIAL-TECHNOLOGICAL SYSTEMS
Examples of the emergence of infectious disease illustrate the intimate in-
tertwining of disease dynamics with socio-political, economic, ecological and 
demographic change. Similar processes can be seen in technological and urban 
developments which produce a wide range of impacts on ecology and human 
health.  These include road accidents, indoor air pollution, threats to women’s 
reproductive health, chemical and biological exposures and so forth.  These 
diverse impacts operate on different time scales with some occurring relatively 
fast and others having long-term, drawn-out consequences.  Some are more 
predictable than others; all occur in varying magnitudes. Although traffic acci-
dents are the fourth leading cause of the current burden of disease (Mathers 
and Loncar, 2006), in this paper we focus on industrial and occupational disease 
because they illustrate particularly well the intertwined dynamics of socio-po-
litical, economic processes, ecological and demographic change. 
The scale of industrial and occupational ill-health is huge and rising. Each year 
270 million workers have occupational accidents, 360 thousand employees 
die and 160 million workers contract occupational diseases (Rantanen et 
al, 2006: 7).9 Industrial diseases are expected to increase as economic shifts, 
business re-engineering, new technologies and changes in work organisation 
occur: ‘(w)hatever happens in the world of work, occupational health remains 
an issue’, said the President of the International Commission on Occupational 
Health in September, 2006.10  Industrial diseases have a long history – in China 
lung damage and lead poisoning from mining have been traced back to the 
Song (1000 B.C.) and Ming (14th-17th Century) Dynasty (Liang and Xiang, 2004). 
In recent times, new patterns of global production have been associated with 
deterioration in workers’ safety, health and work conditions (Rantanen et al, 
2006: 7). In developing countries – where an estimated 2.4 billion people are 
employed, basic occupational health and safety standards are seldom met and 
only 15 percent of workers have access to occupational health services. 
Thurston and Blundell-Gosselin (2005) argue for an ecological understanding 
of the dynamics of industrial health, one that moves beyond the farm or factory 
setting, to examine how wider and interrelated social, physical and environ-
9 Occupational and work-related diseases are not systematically recorded and it is difficult to find 
reliable data on this (Rantanen, Lehtinen and Savolainen, 2004).  In addition, under-reporting of 
health statistics is common in certain sectors, such as farming (Thurston and Blundell-Gosselin, 
2005).
10 http://www.icohweb.org/pres_addr.asp  accessed 6 December 2006
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mental factors affect health. Kirby argues similarly that analysis of urban space 
should include ideas of flux and unexpected consequences in conjunction with 
processes and responses which produce new technologies, new products and 
new by-products (cited in Cutter and Tiefenbaker 2006).  Solecki’s idea of the 
urban environment as a ‘hazardscape’ in which natural, technological and social 
hazards are combined (Solecki, 1990 Cutter and Tiefenbaker 2006) provides 
for a dynamic understanding of how social, physical and environmental factors 
create risk. These approaches, which emphasise risk, flux, unexpected conse-
quences, of social and economic relationships and multiple settings are relevant 
to all situations where industrial health is an issue.  In developing contexts, it is 
necessary to examine the multiplicative nature of occupational disease, injury 
and risk.  Smith and Ezzati (2005) introduce the term ‘risk overlap’ to refer to the 
way that certain communities experience ‘household’ and ‘community’ risks 
simultaneously.  
Cutter (2006) argues that ‘The world is becoming a more toxic place in which to 
live’, pointing out that over a hundred major chemical accidents have occurred 
in the past 20 years resulting in over 8000 deaths and 190 000 known injuries 
(Cutter, 2006b).  In his review of major industrial crises, involving at least fifty 
fatalities, Shivastava (1987) concludes that developing nations are more likely 
to experience these crises due to inadequate safety mechanisms and industrial 
structures.  He argues that the rate of incident and the potential for harm has 
intensified. Downey and van Willigen argue that ‘the poor, the working class, and 
people of colour are disproportionately likely to live in environmentally hazard-
ous neighbourhoods’ (2005: 289).  Their residence in these surroundings has a 
harmful effect on their mental wellbeing and, because this effect is mediated 
through their identity, the results are more severe for minorities and poor than 
for whites and wealthier people.  This local experience of vulnerability is per-
petuated across national and international contexts. Understanding industrial 
health therefore needs to address how political-economic dynamics interact 
with social and technological ones. 
SYSTEM DISTURBANCE: SHOCKS, STRESSES AND LONG-WAVE EVENTS
As preceding sections have shown, complex dynamics impinge on human 
health and will affect any attempt at intervention. Complexity, non-linearity and 
interactions across multiple scales are frequently characteristic of population-
disease systems. They are compounded further by interplay with social, political 
and technological processes, leading to a picture of complex, dynamic social-
ecological-technological systems. Different groups in society often understand 
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and experience such dynamics and their effects in very different ways. Further, 
as we show here, such systems can become subject to disturbances of various 
kinds, whether generated internally to the system (e.g. a shift in the ecology 
of a disease organism, or in population mobility) or externally (e.g. the impact 
of conflict or war, or the arrival of a new disease). While some disturbances 
take the form of relatively short-term shocks, others are manifested as long-
term stresses. As disturbances interact with existing systems dynamics over 
time so this can give rise to complex ‘long-wave events’. In this sub-section we 
discuss each of these kinds of system disturbance in turn. They are, we suggest, 
becoming increasingly prevalent. This underlines the importance of addressing 
the systems properties that enable people and societies to remain resilient and 
robust in the face of disturbance. It also underlines the need to move away from 
equilibrium based policy framings towards approaches that respond to such 
dynamic challenges. 
Short-term shocks
Dominant health policy and development models have paid relatively little at-
tention to questions of dynamics, grounded as they often are in assumptions 
of stability and linear progress. Nevertheless, there has been growing attention 
to the importance of shocks. One example is the World Bank’s social risk man-
agement framework, which focuses on how households employ a number of 
strategies to minimise the risk of shock, mitigate their impact and cope with 
the impact on their livelihood capacity (Holtzman and Jorgensen 2000). This 
might translate in terms of health shocks into a combination of preventive pro-
grammes and increased individual responsibility to reduce risk, the availability of 
competent medical care and mechanisms that enable people to insure against 
uncertainty of costly illness and arrangements to help people cope with disabil-
ity or early death (Bloom 2004a). There is a parallel set of discussions around the 
impact of environmental disasters, war and civil disorder (Wisner et al 2005). 
While many policy debates have understood such shocks as atypical and short-
term interruptions to the ‘normal’ pattern of development, an important stream 
of analysis addresses the differential effects of shocks depending on how they 
intersect with systems dynamics at multiple scales. Thus existing ecological, 
livelihood and household processes affect the impact of shocks on individual 
health and well-being (Wisner et al 2005). At a larger scale, there is growing 
interest in the institutional and political processes that shape how societies ex-
perience and deal with major shocks (Centre for Future State 2005; Fukuyama 
2004; Birdsall 2007). Such factors help to address reasons for divergence: for 
example, why Western Europe could recover so rapidly from the chaos and 
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destruction of the Second World War and the serious health problems that 
resulted (Judt 2006), while southern Africa is having such difficulty managing 
its transition from colonialism and the wars associated with the struggle to end 
apartheid. Thus predisposing conditions and antecedents render some societ-
ies more susceptible than others to shocks. Poverty and associated high levels 
of inequality can feed these processes, spreading or generalising the precipi-
tating biomedical or environmental causes. These in turn are driven by global 
and local interconnections with food insecurity, drought, debt and so on. The 
result can be geographically and socially structured vulnerabilities which drive 
epidemics: for instance, it is not bio-medically coincidental that sub-Saharan 
Africa has been hit hardest by the HIV virus.
Long-term stresses
Long-term stresses are also impinging on many social-ecological technologi-
cal systems, with major implications for the dynamics of health. An illustrative 
example concerns the combined and multiple effects of ageing and demo-
graphic change in the context of a highly populated world. These effects are 
playing out over a far longer time-span than established conceptual frameworks 
and policy approaches can generally encompass. 
The world is undergoing a demographic revolution. There are presently about 
600 million people aged 60 years and over and this is set to double by 2025 
and to reach two billion by 2050 (WHO 2003). Most of these older people will 
be living in what are currently developing countries. The phenomenon of 
global ageing is unique in human history and has significant implications for 
all sectors and across national boundaries (Eberstadt 2004; Mujahid 2006). For 
instance it affects economic productivity with smaller cohorts in the economi-
cally active population and higher dependency ratios. Associated with global 
ageing (although also with other factors) is an increase in the proportion of non-
communicable diseases. The leading causes of morbidity and mortality among 
adults over 60 are heart disease and stroke and these are increasing rapidly in 
developing countries (WHO 2003).  At the same time, elderly people are highly 
vulnerable to any new epidemic disease. The unfolding burden of disease is 
likely to be very uneven across and, indeed, within countries
These shifts in disease pattern, combined with the socio-economic shifts which 
accompany population ageing, are bringing profound implications for social 
dynamics and for health systems. The conditions which typify older age disease 
require different management from acute conditions and episodes of illness. 
They are often associated with impaired mobility and long term dependency 
21
needs. They have implications for the types of personnel required, the regimes 
within which people are supported (both the recipient and their carers) and the 
technologies appropriate to their care. They also have implications for paying 
for treatment and care. The health systems that many low and middle income 
countries constructed to address the problems of a relatively young population 
are poorly equipped to deal with the different patterns of need. Driven by the 
longevity of developed country residents, research and technology develop-
ment are continually expanding the boundaries of available treatments and 
generating expectations that medicine should have a response to every health 
problem. This is leading to a blurring of boundaries between medical treat-
ments and lifestyle or recreational drugs and towards a “medicalisation” of 
ageing, itself. These new treatments are often rather expensive. Poorer people, 
especially, face hard choices about allocation of household resources around 
competing needs, where elderly members require long-term or expensive care. 
Poor countries face similar decisions at the macro level, especially where there 
is continuing high need for resources for endemic communicable diseases 
and maternal and child health in contexts of incomplete epidemiological tran-
sition. Thus ageing and demographic change are placing a variety of stresses 
on systems for dealing with health issues both nationally, locally and within 
households. Responding to these emerging dynamics effectively constitutes 
an unprecedented challenge. 
Long wave events
Some major health shocks play out over a long intergenerational timespan with 
profound long-term consequences. These can be termed long wave events and 
the best known of these currently is the HIV and AIDS pandemic. Other examples 
include the wholly unexpected and unprecedented fall in male life expectancy 
in some countries of the Former Soviet Union starting in the 1980s.11 Another 
is exposure to mass environmental contamination through chemical and other 
toxins. An example of this is arsenic poisoning in Bangladesh as a consequence 
of the unintentional release of naturally occurring arsenic compounds in the 
mass tube well digging programme in the 1990s. This is projected to affect 
between 30-80 million people.12 
11 Whilst life expectancy has declined over the last 30 years, it has declined particularly 
dramatically for men.  In the late 1990s it was estimated to be 71 for women and only 59 for men 
(UNFPA 1998). This is  thought to be due to high increases in deaths among middle-aged men 
from cardiovascular disease as well as external causes such as murder, suicide, accidents and 
poisoning.
12 This has been called the largest mass poisoning in the world and in the worst affected produces 
eventual death by liver and skin cancers (Meharg 2005).
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Long wave health events differ from transient shocks in several ways.  First, their 
initial manifestation is very different.  Not only are we usually not aware of their 
exact starting point, but we also only become aware of them by the accumula-
tion of their apparent effects.  Second, they have very different long-term im-
plications and repercussions, often extending over many decades and probably 
well beyond, with a legacy passed down through several generations, often 
influencing socio-cultural practices and beliefs.  Third, they are complex and 
difficult in intervention terms and tend to be beyond the purview of standard 
policy timeframes (Standing 2005). For instance, few are systematically address-
ing the question of what needs will arise for the grandchildren (let alone the 
great grand-children) of people living with HIV today in the poorest countries, 
or the intergenerational implications of mass environmental poisoning. Fourth, 
because there is a large amplifier effect between the specific characteristics of 
the originating mechanism and its macro-level effects, and because we only 
become aware of these by witnessing the accumulated effects, once we do 
become aware, the event is already well developed and has a deeply established 
backlog of impacts yet to come.  Fifth, long wave shocks are actually a combina-
tion of multiple shocks and complex causalities some of which are irreversible, 
such as climate change (Yamin 2004; Bloom 2004b). Epidemic HIV and AIDS 
is generally associated with intertwined ’accomplices‘ such as food insecurity, 
drought and high levels of poverty and conflict (UNDP 2004). The accomplices 
of the fall in male life expectancy in the former Soviet Union include the collapse 
of earlier employment and state support systems and a crisis in gender identity 
(Leon and Shkolnikov 1998; Ciment 1999). The accomplices of the arsenic crisis 
in Bangladesh include endemic poverty and proneness to major environmental 
disasters, natural and human driven (UNDP 2001).
Long wave health events challenge existing conceptual frameworks, method-
ologies and policy responses (Barnett 2005). In conceptual terms, they require 
a far broader and longer-term view than characterise dominant approaches 
to health problems. In the case of HIV, for instance, a long-wave perspective 
challenges epidemiological and bio-medical approaches that frame the issue 
in terms of individual behaviour change or access to ART treatment. Rather, 
larger and longer-term societal and intergenerational consequences become 
relevant, such as disrupted transmission of socialisation and skills and shifts in 
gender relations which in turn have potentially major macro-social and further 
disease-ecological consequences.
Long wave events also challenge conventional ways of modelling impacts. First, 
these tend to have time horizons which are too short to take sufficient account of 
the long-term impacts on social relations. Second, economic and demographic 
modelling, in particular, often pick out a small number of “obvious” variables 
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and hold constant a range of potential effects and variables that are not within 
their disciplinary purview. But these very variables may overwhelm the original 
model. One example is the gendered impact of changes between market and 
non-market activity. Chronic health problems can affect the balance between 
market and non-market economic activities and between these and personal 
care burdens as households are forced to make labour substitutions or forego 
activities. Such impacts call for more complex modelling, that takes a broader 
social  and ecological perspective, and that attends to the interaction of biologi-
cal, social and economic processes - including other shocks - across temporal 
and spatial scales. 
RESILIENCE AND VULNERABILITY 
The importance of shocks, stresses and long-wave events in disturbing systems 
that are already dynamic, and the many uncertainties that pervade these in-
teractions, highlights the importance of system properties such as resilience. 
Resilience can be considered as the opposite of vulnerability. Whether or not 
a system, or a particular group of people, is resilient or vulnerable to shocks or 
stresses depends, as the sections above emphasise, on much more than biolog-
ical or technological factors. Intertwined socio-political processes are also key 
in shaping vulnerability or resilience both to exposure to the shocks or stresses 
themselves, and to their effects. In turn, both disturbances, and vulnerability/
resilience, may be framed and experienced differently by particular groups of 
people. 
Recent thinking on vulnerability emerging from work on HIV and AIDS illus-
trates these perspectives (Edström, 2007).  This developed in critical response 
to dominant views in the early years of the AIDS pandemic, when public health 
professionals identified the behaviour of ‘high risk groups’ as the key to trans-
mission of the virus, thus attaching the concept of risk to population groups 
as opposed to situations. Information campaigns were implemented to raise 
awareness and reduce individuals’ ‘risk behaviour’. These campaigns rarely suc-
ceeded in fostering the sustained behaviour change they aimed for, particularly 
when campaigns were based on standard messages aimed at heterogeneous 
populations. A different approach adopted by programmers, in the 1990s and 
beyond, moved from a ‘risk’ framework, towards a broader focus on vulnerability 
(Edström et al., 2002; Bates et al. 2004). This aimed to move beyond a focus 
on individual behaviour to contextualise and address community level determi-
nants of vulnerability, including culture, gender and poverty. In some versions 
of this framework, a broad range of social factors is emphasised to the extent 
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that biological dimensions of susceptibility and sensitivity within vulnerability 
disappear altogether, losing sight of the virus.  Yet as others have shown, it is the 
interaction of disease, social, economic and political dynamics that is key, con-
tributing to a complex set of interlocking vulnerabilities (Barnett and Whiteside, 
2002; de Waal, 2007). Thus for instance the impacts of AIDS generate specific 
shocks, such as sickness and loss of parents, or labour; these are compounded 
by others, such as droughts or hyperinflation; and influence yet others, such 
as a resurgence of old health problems (such as TB or malaria) or the creation 
of new dimensions of stigma and discrimination against already marginalised 
people. Global and local social and cultural contexts are thus co-evolving with 
the virus and with other new disease ecologies.
To understand vulnerability in relation to HIV or other major hazards requires 
combining two basic senses of vulnerability (Chambers 1989; UNDP 2004, 
Edström, 2007); vulnerability to exposure (UNAIDS 2001; Bates et al. 2004), and 
to potential impacts (Barnett and Whiteside 2002, Morton 2005; Gillespie 2006). 
The vulnerability of an individual or particular group also combines embodied 
and personal biological and psychological dimensions, with contextual social, 
environmental and political dimensions (Plumber et al. 2001; Bates et al. 2004). 
Resilience can be considered as the flip-side of – rather than the absence of 
– vulnerability – again dependent on the interaction of biological and social di-
mensions.  Vulnerability, with frequent exposure to perceived hazards or stress, 
coexists with and creates agency and resilience, including avoidance capacity 
(Sinha and Lipton 1999).
As the debate about vulnerability/resilience in relation to HIV emphasises, then, 
resilience is a property that is itself part of dynamic systems. It involves not just 
bio-physical and ecological conditions but crucially, the ways these interact 
with socio-cultural processes and power relations. Such perspectives also draw 
attention to the possibility that different people and groups understand and ex-
perience vulnerability/resilience (and the dynamics shaping it) in different ways 
- linked to different notions of what Sustainability might be. 
IMPLICATIONS FOR SUSTAINABILITY
The degree to which a system is resilient in relation to shocks and stresses 
- as well as related properties such as robustness, stability and durability (see 
STEPS Working Paper 1 on Dynamics) - are key to whether it is Sustainable. 
Whether at the scale of a household, community or a nation, and whether the 
system is centred on disease-ecological-social-technological dynamics or also 
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structured around health service interventions and institutions (what is often 
termed a ‘health system’ in the literature), such properties are central to the 
pathways to Sustainability or otherwise that may emerge over time. The notion 
of Sustainability (as opposed to sustainability in a general sense) recognises the 
particular Sustainability goals that different groups in society might hold, as 
linked, for instance, to their notions of wellbeing, or livelihood or development 
priorities. 
The discussion above has emphasised the importance of considering pathways 
to sustainability in ways that depart from linear views of human, social, techno-
logical and ecological development. Pathways involve both complex dynamics, 
and major uncertainties. Thus it is difficult accurately to predict the relative im-
portance of different factors over different time scales. Although for instance 
one can say with confidence that, in the absence of major technological 
advances, there will be major epidemics of new diseases or untreatable forms 
of existing ones, it is impossible to define whether the time scale is in years or in 
generations. Although one can say with certainty that the HIV epidemic and the 
consequences of demographic change will have enormous social, economic 
and health impacts over the next few decades, the ways these will play out in 
different places, and amidst the complex dynamics of viral resistance, are hard 
to predict. And while one can predict with confidence that new technologies 
will create new ways to relief human suffering and new approaches for making 
these technologies widely available, how different societies will receive and 
adapt them is more uncertain. The combination of inexorable and predictable 
change and highly unpredictable and potentially major risks and uncertainties 
presents great challenges to individuals and societies.
There are growing divergences between localities and population groups in both 
economic development and health (Wade 2003). Regions have very different 
trajectories of development and disease ecology, and pathways to Sustainability 
are conditioned by such divergent, dynamic contexts. Recent reports have 
identified two particular kinds of area and population group where complex, 
unfolding dynamics are leading to particularly significant Sustainability chal-
lenges (Brower and Chalk 2003; Brownlie et al 2006). These suggest valuable 
case study foci for the STEPS Centre.
One constitutes the many parts of Asia experiencing radical economic and 
social change associated with very rapid urbanisation, technology-led economic 
growth, increasing standards of living and changing patterns of inequality and 
social segmentation. This is creating densely populated urban centres and ex-
panding peri-urban fringes. There are often rapid increases in meat consump-
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tion with consequent changes in animal husbandry. Economic growth, demo-
graphic and epidemiological transition and accompanying rises in demand for 
health services have outstripped the capacity of organised health systems. This 
has encouraged the emergence of highly pluralistic health systems. The rapid 
spread of market relationships has encouraged more individualistic approaches 
to problems and less willingness to rely on governments. Rapid economic 
growth has contributed to rising expectations of the benefits of medical care 
and strong demands for the latest drugs and medical interventions. In addition 
to generating unnecessary costs, this increases the risk of treatment induced 
complications and antibiotic resistant organisms. These areas are potential 
centres for the emergence of new health challenges. They are also likely to be 
centres of institutional innovation in response to these challenges.
A second constitutes places that have experienced economic, social and 
institutional decay associated with shocks and long-wave events that have 
overwhelmed social coping mechanisms. Many are found in sub-Saharan 
Africa. Contributing processes include varied combinations of post-colonial 
or post-revolutionary transition, economic crisis, civil disorder or cross-border 
conflict, and periodic ecological disasters and chronic ill-health, including infec-
tion with HIV. The lack of access to effective family planning and the associated 
high rates of population growth is an important contextual factor (Cleland et al 
2006). Some countries have experienced decay in government systems and in 
community and family coping arrangements. This can lead to the concentration 
of people in peri-urban settlements, camps for displaced people or poor rural 
hinterlands. The combination of drought and dwindling water supplies linked to 
climate change, poor sanitation, compromised immunity associated with mal-
nutrition and chronic disease and weak health systems leading to widespread 
and inappropriate use of drugs raise the risk of the emergence of new diseases, 
the development of treatment resistant versions of existing diseases and the 
amplification of epidemic disease arising elsewhere. 
Health in today’s world is thus strongly conditioned by dynamics - in human-eco-
logical systems, in interlinked social and technological systems, and in the inter-
action of these with shocks and stresses over multiple scales. Such dynamics 
lead to the possibility of multiple pathways conditioned by dynamics, replete 
with uncertainties. These unfold in different ways in particular places, as shaped 
by their contexts and histories. While some pathways may lead to Sustainability 
as valued by particular people and societies, others may not, instead precipitat-
ing increased vulnerability, poverty and social injustice. In responding to health 
challenges in this context, much current thinking around policy, institutions, 
management and regulation is inadequate. Reliant on linear, predictable models 
of change and on assumptions of stable institutions, it informs approaches that 
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are not up to the task of dealing with dynamics, complexities and uncertain-
ties. Rethinking governance approaches in relation to health is thus an essential 
challenge, and one to which we turn in section 4.
4. ADDRESSING HEALTH GOVERNANCE CHALLENGES
This section focuses on changing political and institutional processes for ad-
dressing health-related challenges. As described in section 2, dominant models 
have assumed that states, with international support, could and would plan for 
and deliver modern health services to their populations. They have also assumed 
that organisational arrangements are easily transferable between social and 
economic contexts. Yet emerging institutional and governance arrangements 
in many countries challenge these assumptions, revealing new dimensions 
and complexities in the interactions between multiple actors across scales, and 
in the politics of knowledge. STEPS Working Paper 2 presents an overview of 
these transformations in governance in general terms. This section, in tracing 
some of their specific manifestations in the health context, echoes the broader 
paper in revealing problems in blueprint approaches to institutional develop-
ment that rely on importing models from outside. There is a need to focus on 
arrangements that work in particular contexts - such as  innovative examples of 
partnership between the state and civil society around the delivery of services 
(e.g. Centre for the Future State 2005). The construction of institutions and ap-
proaches must also be understood as a political process, in which deliberation 
and reflexivity amongst different actors who might frame system dynamics and 
goals in different ways is essential. 
Indeed, questions of knowledge and framing are central to health governance. 
If health systems can be understood as ways of producing and organising 
access to expert knowledge and the technologies that derive from it (Bloom and 
Standing 2001; Bloom et al forthcoming), questions arise about how such forms 
of expertise represent systems dynamics, and respond to the Sustainability goals 
of different groups.  In many countries, far-reaching changes have been taking 
place in the power relations and institutions which mediate the production and 
dissemination of health-related knowledge. Some of these changes and points 
of instability are outlined below, addressing, in turn, shifting relationships in-
volving markets, state-society relations, citizenship, and global institutions and 
governance. As we will argue, dynamics, and the ways they are understood, both 
shape and are shaped by governance arrangements.
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PLURALISTIC HEALTH SYSTEMS AND MARKETS
The reality of health systems in many low and middle-income countries is very 
different from the vision of the Health For All Strategies of the 1970s. Bloom 
and Standing (2001) describe highly pluralistic health systems with a variety of 
service providers and sellers of health-related commodities operating in formally 
unregulated markets. Mackintosh and Koivusalo (2005) document widespread 
commercialization of health care with limited or no regulation.
Pluralistic health systems have arisen as a response to several factors, including 
broader political, economic and technological dynamics. Economic and struc-
tural crises behind the problems of many public sector systems have hastened 
the spread of markets as shortages and the livelihood strategies of health 
workers have contributed to a dramatic increase in the use of private providers. 
In many countries the boundary between public and private health sectors has 
broken down and public health providers commonly engage in market-like ac-
tivities. At the same time, open availability of pharmaceuticals and the training 
of large numbers of paramedics has fed the growth of unregulated markets in 
health care through drug outlets and private entrepreneurs. 
The pluralistic health systems of the early 21st Century are very different from the 
post-colonial and/or post-revolutionary systems that Health For All Strategies 
were designed to strengthen. Individuals can now, at least potentially, choose 
between a wide spectrum of providers of health-related services and they can 
buy almost all drugs and medical commodities in organised and unorganised 
markets. These markets create major uncertainties for people seeking the ap-
propriate providers to consult, creating significant instability of responses. They 
give much influence to the expectations of users, which in some instances can 
lead to overly optimistic expectations of technology and a tendency to seek 
large quantities of expensive care. They give a lot of influence to market actors 
and their efforts to generate demand through advertising and other channels. 
They also create major financial barriers to access to care. The most common 
policy response has been to call for more effective regulation and ‘better’ gover-
nance by the state. However, the same dynamics that led to the development of 
these pluralistic markets undermine the appropriateness of established arrange-
ments premised on stability and stable institutions (Bloom et al forthcoming; 
Peters and Muraleedharan forthcoming; Ensor and Weinzierl 2006), requiring a 
rethinking of regulation appropriate to plural, and rapidly changing systems. 
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STATE INSTABILITY, POLITICAL CULTURE AND POLITICAL ECONOMY
Pluralistic health systems exemplify the limited reach of formal, institutional ar-
rangements in many low-income countries. This may always have been the case 
in many areas: thus Mamdani (1996) traces the creation of regulatory systems 
confined to participants in the “formal” economy to the late colonial period, 
leaving the remainder of the population with limited contact with these struc-
tures and relying heavily on more informal social arrangements. Duffield (2001) 
argues that the decay of government structures associated with shocks and 
stresses linked to prolonged civil disorder and warfare have led to an increasing 
reliance on informal arrangements outside the state sector, especially in many 
African countries. Gough and Wood (2004) suggest that informal, community 
arrangements now play a key role in providing resilience and meeting health 
needs in many countries. 
Pritchett and Woolcock (2004) suggest that a major reason for the lack of ‘success’ 
of state arrangements is that the organisational models from advanced market 
economies, on which they have been based, do not function as expected, given 
both prevailing socio-political dynamics, and the different political histories and 
ways of ‘doing politics’ (or political cultures) in the settings of many developing 
countries. For instance, formal rules and norms of behaviour may conflict with 
political-culturally embedded patronage systems. They may thus prove ineffec-
tive in discouraging powerful people from acting against the interests of the less 
powerful. This applies particularly to health service activities that involve much 
interaction between providers and users of services and which require much 
discretion on the part of technical experts. However, embedded ways of doing 
politics have their own, culturally-valued logics (e.g. Bayart 1992, Hyden 1983). 
Thus viewed from the perspectives of those involved, patronage systems may 
have a logic that benefits both patrons and clients in culturally-valued terms. The 
mismatch between the logics of formal state health system arrangements, and 
those embedded in political history and culture, is often vast. It is only widened 
by approaches that assume that imported models will ‘work’ as expected and 
then treat failure as implying the need to reapply the same model with greater 
force (see Fairhead and Leach forthcoming). 
Governments face conflicting pressures in formulating health development 
strategies. Formal health systems rely on a belief in social and political stabil-
ity: that providers and regulators of services will adhere predictably to certain 
socially accepted rules to perform effectively (Gilson 2003; North 1990; Denzau 
and North 1994). In the absence either of these rules and associated behav-
ioural norms, or of shared value in their logics - both characteristics typical of 
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dynamic, multiply-framed systems - health institutions have low capacity to 
respond to individual or societal health challenges. It is particularly challenging 
to create institutions that command wide acceptance in the context of deep 
structural inequalities and historical segmentation in service access (Bloom 
2001), as well as deep divisions in people’s framings of what constitutes an ap-
propriate Sustainability goal  Building consensus around institutional arrange-
ments that are understood to be legitimate, fair, enforceable and appropriate in 
a given context is thus a political process requiring deliberation, whose outcome 
depends on the breadth and effectiveness of participation (Farmer 2005). 
The growing political profile of health has nevertheless created new politi-
cal spaces for such deliberation and struggle over the construction of health 
systems and policy to take place. The creation of mechanisms for citizen par-
ticipation in planning in Brazil (Cornwall and Shankland forthcoming) and the 
increased willingness of the Chinese media to document serious problems in 
the health sector are examples from very different settings of a rising political 
engagement with this issue. Political debates about pathways to Sustainability 
in health and the roles of government, the market, civil society and citizens in 
constructing this future are set to grow.
CHANGING RELATIONSHIPS AROUND HEALTH-RELATED KNOWLEDGE 
Since the late 19th century professions have been the main way of defining 
and managing access to ‘expert’ knowledge in health and have been one of the 
major organisational exports from Europe and North America. Health profes-
sions arose out of struggles between states, markets and providers to regulate 
pluralistic environments, define competent practice and restrict entry to health 
practice. However, this kind of professional model has arguably been trans-
planted less successfully in some other parts of the world. A number of authors 
have noted that professions have considerably less power and autonomy vis-
à-vis the state in many developing countries (Nigenda and Solozano 1997, 
Iliffe 1998) and that this manifests in incomplete professionalisation and weak 
maintenance of standards. Others have argued that professions have managed 
to wrest greater autonomy from the state as a consequence of its failing regula-
tory capacity and the flight of state-employed practitioners to private practice 
(Mutizwa-Mangiza 1999). So the extent to which professions have been able to 
create and maintain a monopoly of expert health knowledge is variable across 
the world. This has implications for the kinds of arrangements that are likely to 
emerge in terms of how expertise is made accessible to users, whether through 
mediated or unmediated ways.
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Professions are complex institutions which embody potentially contradic-
tory characteristics which play out in different ways as environments change. 
Professions and professionals bring with them particular understandings 
of bodies, diseases and health management. These combine to ‘frame’ the 
social-ecological-technological systems with which health is integrated in dif-
ferent ways, some grounded in equilibrial notions, others more dynamic.  In the 
advanced market economies, two trends have been particularly evident.  One is 
a degree of transformation of professional practice through greater non-medical 
concerns and oversight. Examples are non-medical management, stronger cost 
control measures and patients’ pressure groups. The other is what is seen as a 
more generalised distrust of “experts” , and a redefinition of expertise to encom-
pass lay and experiential forms, as older established hierarchies of control and 
ideologies of scientific certainty and paternalism are challenged (Williams and 
Calnan 1996). This brings with it diverse and often contested framings of health 
knowledge from different groups- doctors, lay people, patients and so forth.
For both developed and developing countries, two key issues are evident. First, 
the so-called ‘problem of trust’ manifests itself in a different way in developing 
countries (Gilson 2005). Medical knowledge tends to be more pluralistic, with 
often well established systems of non-allopathic practice. These systems have 
their own traditions of managing access to expertise which are more socially 
embedded and may be more trusted. Second, and by contrast, the bio-medical 
professions have a much shorter history of implantation and their monopoly 
of expert knowledge is increasingly being challenged by changes from several 
directions, global and local. It is useful to outline these challenges. 
A first relates to the weakening of regulatory systems manifested in the growing 
marketisation of health care services.  Iliffe (1998) argues, in the context of East 
Africa, that the greatest threat to professional monopoly has been the rise in 
self-treatment from pharmacies. Self-treatment has been shown from health 
expenditure surveys in many countries to be one of the main resorts of people, 
particularly the poor, in pluralistic environments. 
Second, there are increasing challenges to the authority and legitimacy of pro-
fessions as guardians of privileged knowledge, and to the framings they embody, 
as information becomes increasingly available to a whole range of service provid-
ers. These include a growing number of informal providers who have picked up 
information from working with qualified practitioners, or from an eclectic range 
of sources. Users of health knowledge have also increasingly gained access to 
such information through the market in services and from sources such as the 
media and in some places, the internet.  Such rapid changes in the availability 
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and spread of health-related information threaten the gate-keeping roles and 
functions of professional knowledge institutions. Pharmaceuticals, which are in 
theory restricted to prescription, are now often freely available over the counter 
or mediated by a pharmacist. Marketised health care tends to bypass regulated 
referral systems or create its own informal referral networks which cut across 
the formal ones. Other routes to health knowledge, such as informal networks 
and internet sites, present unmediated forms of access (Lucas forthcoming). 
People increasingly access, select and sometimes re-interpret health-related 
information for themselves. The rise in access to diverse forms of health-related 
knowledge has paralleled and been linked with an increase in the availability of 
medical goods. In many places drugs are available from several sources, as are 
diagnostic technologies.  Internet-based services for self-testing for sexually-
transmitted illnesses are just one example. Self-diagnosis and treatment is 
an obvious option in a situation characterised by informed consumers and a 
choice-rich environment of health provision.  Advertising of these products can 
increase awareness of clinically defined disorders and influence how responses 
to certain conditions come to be conceptualised. 
Third, evident failures of established experts to address or deal effectively with 
health-related issues and crises have contributed further challenges to the 
monopoly of expertise.  In OECD countries, such challenges have been linked 
to well publicised scandals such as Bovine Spongiform Encephalopathy (BSE) 
in cattle and people (Van Zwanenberg and Millstone 2003). In developing coun-
tries, such perceptions of failure amongst experts have tended to be more 
related to problems of chronically poor service delivery, such as absenteeism of 
providers and poor quality of services and to failures in drug regulation and the 
widespread availability of sub-standard products (Bloom and Standing 2001). 
Fourth, there is growing evidence of challenge to biomedical epistemologies 
and framings as the sole source of legitimacy for defining and addressing 
health-related problems. People in diverse settings have long made use of a 
variety of forms of knowledge, non-biomedical as well as biomedical, in health-
seeking, as established literatures on medical and therapeutic pluralism have 
long emphasised (e.g. Baer 1995, Janzen 1978, Scheid 2002). Medical sociology 
and anthropology have documented how people combine different therapeutic 
forms - biomedical Islamic, and herbal for instance - in sequences to address a 
given ailment; the culturally-grounded ways that biomedical diagnoses, drugs 
and treatments are interpreted (e.g. Bledsoe and Goubaud 1986), and how the 
existence of plural providers can influence the ways each operates (as in the 
formalisation of traditional healing, Last 1986). Likewise, the interplay between 
formal biomedical framings of health issues, and the - often very different - 
ways that illness and therapy are experienced - has long been recognised (e.g. 
Kleinman 1988).
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Yet several more recent features of the health-knowledge landscape are coming 
into view. These include recognition that the very categories and distinctions 
- of  biomedical and non-biomedical, modern and traditional, as well as others 
such as between public and private health institutions - may not make sense to, 
and shape the health-seeking practices, of local populations. Such categories 
are legacies of colonial and post-independence models of health systems and 
practice, and continue to dominate and be reproduced through research and 
practice  in relation to formal health delivery systems. But quite different distinc-
tions may be as central to people’s actual health-seeking and reflection on it, as 
in rural Guinea where more salient to local thinking and practice are distinctions 
between gendered spaces; strength-building vs. cure; certainty or ambiguity 
of ailment; injection vs. oral therapies; and quality, all of which cut across bio-
medical-traditional divides (Fairhead et al forthcoming). In a similar way, in the 
UK, recent parental thinking and practice around vaccination has been shaped 
by tensions between individualistic framings and population/social framings 
of possible vaccine effects - each framing involving a cluster of biomedical 
and non-biomedical perspectives with broader value questions (Leach 2005, 
Fairhead and Leach forthcoming). 
More recent features also include growing popular and patient critique of, and 
challenge to, conventional biomedical perspectives. These challenges have 
been particularly evident in European and US settings. They frequently involve 
issues where medicine is seen to be failing or to have little to offer - such as 
the management of reproduction, chronic illness (e.g. Anderson and Bury 1988) 
or disability (e.g. Oliver 1990). They also, and increasingly, involve areas where 
biomedical interventions are seen as experimental, ethically questionable, or as 
replete with risks and uncertainties, such as transplantation and new reproduc-
tive technologies, or certain vaccinations (Fairhead and Leach forthcoming) 
- as well as environmental and public health issues (Gabe et al 1994). Recent 
years have also witnessed widespread growth in the popularity of ‘alternative’ 
or ‘complementary’ therapies (e.g. Sharma 1992). These trends suggest signs 
that western consumers, at least, are coming to distance themselves culturally 
from some aspects of orthodox medicine. Yet Williams and Calnan (1996: 1617) 
suggest that such critiques involve a process of ‘lay re-skilling’ that does not 
just reject but often appropriates elements of biomedicine, linking them into 
agendas that better suit peoples’ experiential and political agendas. They see 
this as a pervasive reaction to the expropriating effects of biomedicine, and 
modern systems of knowledge and expertise more generally in late modern con-
ditions. Questions arise, however, about the extent and forms of such critique 
and challenge in transitional and developing country settings, where often the 
dominant political concern is to extend access to what is widely perceived to be 
effective medical care.
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NEW FORMS OF HEALTH-RELATED CITIZENSHIP
The changing, more pluralistic, politics of knowledge in the health field are linked 
with the emergence of a wide variety of citizen and advocacy groups and gov-
ernance networks. These often draw on critical ‘lay’ perspectives and forms of 
experiential expertise (Collins and Evans 2002, Williams and Popay 1994). Some 
are constituted around ‘citizen science’ (Irwin 1995), where people conduct 
their own investigations and assemble evidence in accordance with their own 
experiences and framings of the issues concerned - as, for instance, in cases 
of popular epidemiology around environmental health issues (e.g. Brown and 
Mikkelsen 1990). Such forms of action reveal active citizen engagement in the 
politics of knowledge around issues involving science, technology and health 
(see Leach et al 2005). Manifestations in the health field range from self-help and 
self-treatment groups, to demands for and sometimes orchestrated opportuni-
ties for inclusion in policies and decisions around health issues and controver-
sies. They include a variety of mobilisations and movements, whether claiming 
rights to drugs or treatments, demanding regulation of the quality of drugs and 
medical practices, or questioning biomedical interventions and policies. While 
some remain confined to particular localities, others link with national and in-
ternational actors in new trans-national networks, often facilitated by globalised 
media and communications. The Treatment Action Campaign (TAC) that linked 
South African township dwellers with networks of global activism in the success-
ful struggle to secure low-cost anti-retroviral drugs from global pharmaceutical 
companies has rapidly become an iconic example of this emergent ‘globalisa-
tion from below’ of health politics (Robins 2005). 
Mobilisation has taken place around a number of issues including government 
provision of services and a number of initiatives to organise community health 
insurance and micro-credit as important sources of health finance. However, 
this paper focuses on cases where specific diseases have formed the basis for 
mobilisation. These can be of a life-threatening nature, such as in the case of 
HIV/AIDS or certain cancers, or the example of diabetes patient support groups 
in Cambodia13.  Where a disease carries considerable stigma, a shared experi-
ence of discrimination can be offset by group acceptance and solidarity. Access 
to drugs and expertise has been the rallying cry of the groups that have gained 
international prominence. In the UK, the mobilisation to gain access to suppos-
edly life-saving new cancer therapies, such as Herceptin, attracted consider-
able publicity as individuals won a court case against primary care trusts at the 
European court of human rights. 
13 Personal communication from Maurits van Pelt.
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The case of mobilisation around HIV/AIDS provides a good illustration. Civil 
society actors have often led the way in vertical, horizontal and ‘virtual’ group-
ings. The main thing that unites them is a passionate, and sometimes desper-
ate, drive to respond to the challenges, on the one hand, and their diversity, 
on the other. The group most affected by HIV/AIDS, as well as being key to the 
dynamics of HIV/AIDS, is of course people who are already positive. This is a 
very diverse population, however, which presents many challenges for mobilisa-
tion and involvement.  The situation in South Africa, where risk, exclusion and a 
struggle for survival coexisted with a robust championing of a new discourse of 
human rights as an enterprise of nation-building has influenced the form that 
mobilisation for anti-retrovirals has taken under the banner of the constitutional 
right to health. Robins (2005, 2006) emphasises the potential of health-related 
activism, strong illness identities and the scarcity of treatment to shape new 
subjectivities and types of health/biological citizenship. Nguyen (2005), in ana-
lysing AIDS activism in Burkina Faso, describes a ‘biopolitical citizenship’ that he 
calls ‘therapeutic citizenship’ which encompasses ‘claims made on a global 
social order on the basis of a therapeutic predicament’” (ibid:126). Nguyen’s 
emphasis on the broader industry that has arisen around HIV/AIDS issues, the 
heterogeneous conglomeration of different actors and the activation of global 
networks, captures something of the characteristics of the ‘new social move-
ments’ that have mobilised around issues pertaining to health. These emergent 
forms of civil society mobilisation rely heavily on alliances that transcend national 
boundaries and connect local groups to key global players and knowledge. They 
are part of networked governance arrangements that are increasingly signifi-
cant in shaping and responding to contemporary health dynamics.
Mobilisation is also taking place around concerns regarding risks and uncer-
tainty associated with medical technologies and their application. Citizens may 
campaign for greater transparency on the part of medical scientists or the state, 
recognition of their experiential expertise, or greater regulation. The campaign 
against the combined MMR vaccine in the UK (Leach 2005) is one example.14 
Yahya (2006) describes a similar situation in Northern Nigeria, where critique 
of modern medical discourses fed resistance to government-led campaigns 
for immunisation against polio. The response to HIV in some countries has 
included a questioning of biomedical approaches and the advocacy of a variety 
of alternative treatments or hoped for pathways to Sustainability in health. This 
has sometimes included a resistance by government to provide access to treat-
ment with anti-retroviral drugs.
14 Certain parents were concerned about a supposed link between MMR vaccination and the 
development of autism in children. They were afraid that the denial of the veracity of the research 
and the continuation of large national public health initiatives were undermining their ability to 
make their own choice as to whether to avoid vaccination entirely or to request single vaccines.
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Concerns about regulation and transparency are also evident in instances where 
groups mobilise around environmental exposure to harmful substances. Often 
the central issue is access to a range of social protection mechanisms, as in the 
case of Chernobyl (Petryna 2002). A related situation can be seen in the case 
of occupational exposure, such as asbestos mining and the link to asbestosis. 
Again fights for compensation from large mining companies have been a key 
issue (Waldman 2005). In certain instances people will mobilise for the purposes 
of fighting for the legal acknowledgement of their conditions as a ‘real’ medical 
entity or disability, such as occurred with Gulf War Syndrome (Kilshaw 2004).
A variety of factors seem to shape the success, sustainability and impact on the 
sick of these forms of health-related mobilisation around the politics of knowl-
edge (see Leach and Scoones 2006). At a national level a political climate that 
allows dissent is important. The case of HIV/AIDS suggests that the strength of 
commitment to the cause has been mediated by a strong group identity and 
also self-interest. The role of charismatic leadership is also key, as is the nature 
of the connections the leadership can forge. A well-networked organisation 
with access to legal connections and the sponsorship of powerful individuals, 
for example in the government or public sector, can have considerable influ-
ence. Frequently a strong backing from other civil society organisations is also 
evident, such as local or foreign NGOs. The reality of ‘citizen mobilisation’ is 
complex, with symbiotic relationships spanning local-global dynamics and dif-
ferent groups sometimes co-opting each other’s interests. The picture becomes 
particularly layered as movements ‘scale-up’ over time. 
New dynamics involving citizens’ groups are also evident in the development 
of new drugs and the production and distribution of existing ones. A variety of 
so-called public-private partnerships has emerged for this purpose. They often 
involve government, foundations, civil society organisations and for-profit 
companies. These partnerships have had some notable successes in increas-
ing access to immunisation and to treatment of some infectious diseases. The 
growing literature on such partnerships reveals the difficult balances to be made 
between the social need for the development and distribution of safe and effec-
tive drugs and the special interests of members of these partnerships (Buse and 
Harmer 2007). There is always a danger that the powerful will disproportionately 
influence a partnership. The relationship between large pharmaceutical compa-
nies and patient groups and health related activism is a case in point. 
The Herceptin case in the UK illustrates the murky waters of industry involve-
ment in sponsoring breast cancer sufferers to challenge the decisions of 
certain primary care trusts not to supply the drug. In one account, a prominent 
academic revealed how Roche agents attempted to provide her with a strong in-
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centive (namely access to treatment) to take action against her trust and speak 
out (Boseley 2006). In this case, considerable pressure and publicity ensured 
that the drug was evaluated by the National Institute of Clinical Excellence in 
record time and, some argued, before sufficient evidence was available as to its 
efficacy or safety. A similar debate has emerged in the United States concerning 
the involvement of pharmaceutical companies in lobbying for government pro-
vision of immunisation against Human Papiloma Virus, associated with cervical 
cancer.15
Similarly, interactions between the pharmaceutical industry and HIV activists 
exemplify links that, in this case, have enabled large pharmaceutical com-
panies to ensure some benefits even from mobilisation that on the face of it 
challenged their practices. The global community’s difficulties in responding 
to the HIV/AIDS epidemic with available treatment regimens, combined with 
global and local treatment activism, resulted in a growing pressure for access 
to anti-retroviral treatment over the 1990s and beyond the turn of the century. 
The conceptualisation of AIDS as a security threat in the USA, with massively 
increased donor resources combined with declining drug prices, have led to an 
international commitment and momentum to roll out ARV drugs on a massive 
scale in developing countries. Despite initial clashes with certain governments 
over exemption from patent protection and pricing, the industry naturally re-
sponded to new opportunities for expanding markets.16 It is making consider-
able efforts to establish a reputation for social concern reflecting, perhaps, the 
importance to the leading companies of maintaining political support for higher 
prices in the advanced market economies than in low-income countries. Such 
cases illustrate shifting, networked relationships between citizens and private 
actors that are of growing significance in the health field, yet poorly captured by 
conventional governance debates. 
The re-medicalisation of the response to HIV has resulted in a decreasing 
emphasis on primary prevention. It has also created major challenges as health 
systems attempt to greatly expand access to effective use of drug therapy, 
whilst minimising the risk of the emergence of treatment resistant viruses (Van 
Damme et al 2006). This has led to an increasing recognition of the need for 
new forms of relationship between public institutions and people as patients 
and health providers. Robins (2005) writes of the fear of anti-retroviral drug re-
sistance in South Africa and growing talk amongst public health professionals 
15 Washington Post editorial, 11 February 2007.
16  Both for securing continued sales of drugs with expired or expiring patents and for building the 
conditions, client base and needs for new formulations of drugs.
38
and others of ‘responsibilised’ citizens, citizens with rights but also responsibili-
ties. Such ‘clients’ would follow certain behavioural specifications, such as ad-
herence to treatment and disclosure of their HIV positive status. The backing of 
social movements is key as health providers endeavour to balance a population 
perspective with a discourse of individual human rights that has been so promi-
nent as a banner of HIV/AIDS activism. As fear of virulent multi drug resistant TB 
grows in tandem with the risk of retroviral drug resistance, the challenge to find 
effective forms of regulation responsive to citizens’ own framings and rights 
claims will increase. 
GLOBAL GOVERNANCE: NEW FORMS AND NEW CHALLENGES
New political and institutional relationships are also emerging in the terrain of in-
ternational health. A wide variety of organisations now play roles across national 
boundaries in supplying and financing services, seeking to influence govern-
ments and regulating aspects of the health system. Echoing the emergence 
of multi-level governance arrangements around technological and ecological 
issues more broadly (see STEPS Working Paper 2 on Governance), this is creating 
new kinds of relationship and network linking states and local and international 
actors in the health field. As with national and local networks, these emergent 
governance relationships are both responses to and are shaping dynamic socio-
political, technological and ecological systems.
One, relatively well-established dimension of these emergent trans-national 
relationships concerns the increasing involvement of the governments of all 
advanced market economies in the health systems of low-income countries. 
This involvement has gradually shifted from funding investment in infrastruc-
ture and training to co-financing health services. This has led to the establish-
ment of a long-term presence of bilateral and multi-lateral donor agencies and 
also fostered the rapid growth of non-government organisations in the health 
sector of a number of countries. 
During the 1990s donor agencies became increasingly convinced that poverty 
reduction required long-term financial commitments for service delivery. This 
led to the development of new aid instruments, such as sector wide approaches 
and budgetary support for multi-year agreements between donor agencies 
and government. These agreements characteristically include a variety of 
government commitments, often articulated in a poverty reduction strategy 
programme, as a condition for financial support. The implementers of these 
programmes are accountable to the polities of the donor countries as well as 
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to the local population as symbolised in the expression ’development partners‘. 
Donor agencies and recipient governments are still adapting their practices to 
manage ’co-accountability‘ to different constituencies.
Another factor that has encouraged governments of donor countries to support 
health services in other countries has been the understanding of certain health 
benefits as global public goods (Kaul et al 1999). In some cases, such understand-
ings are a response to concerns about dynamics involving the unpredictable 
mobility of people, animals and microbes. This has been associated at national 
levels, particularly in the United States, with an increasing perception of certain 
public health challenges as national security issues (Brower and Chalk 2003; 
Dodgson and Lee 2002; Altman 2003). This has elevated the profile of public 
health, especially infectious diseases in the advanced market economies.  It has 
also given more prominence to the concerns of the electorate in the richer and 
more powerful countries in the development of global policy responses. The 
U.K. Government has recently published a report that strongly argues the need 
to view health as a global problem (Donaldson 2007). These concerns have led 
to the creation of large global initiatives to immunise children and prevent and 
treat several diseases. These initiatives derive funding from both governments 
and large charitable foundations. The most prominent is the Global Fund to Fight 
AIDS, Tuberculosis and Malaria, which has committed $7.1 billion for projects in 
136 countries.17 
The rules of the World Trade Organisation are gaining increasing influence 
over global health systems. The most prominent area of concern has been the 
protection of intellectual property rights and pharmaceutical products and the 
negotiation of the rights of government to procure low cost products to address 
a public health emergency (Correa 2002 and 2004; Subramanian 2004). Over 
time, the opening of markets for health services will become increasingly im-
portant.
These emergent global arrangements contrast strongly with the situation pre-
vailing from the second half of the 19th Century, in which nation states were the 
principal locus of regulatory effort and international agreements essentially re-
flected perceived balances in national interests. Of course, this did not preclude 
countries from interfering directly in colonies and elsewhere. Fidler (1998) 
suggests that international agreements based solely on national interest are no 
longer adequate to the rapid emergence of health challenges. He focuses par-
17  See website of the Global Fund http://www.theglobalfund.org/en/
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ticularly on the role of the World Health Organisation, arguing there are strong 
grounds for the establishment of a mandate that transcends national boundar-
ies. In this he follows functionalist analyses of the development of governance 
structures, saying little about the influence of power or framing in the design 
of global regulatory regimes. He argues that the response to the 2003 SARS 
epidemic was the first to reflect the “post-Westphalian” world in which national 
sovereignty is not absolute (Fidler 2004), although others would suggest that it 
prevailed earlier - evident for instance in the ‘un-national sovereignty’ of WHO 
smallpox vaccination campaigns in Africa in the 1960s and 70s (White 2005) 
and health interventions associated with military interventions. Fidler bases 
his argument on the role of the WHO in limiting the capacity of the Chinese 
government to deny the existence of a serious outbreak. His argument about 
the limitations on the power of even a very strong government to control in-
formation flows is convincing. However, it downplays the role of citizen action. 
According to Saich (2006), Guandong Mobile reported that the message ‘there 
is a fatal flu in Guangzhou’ was sent around 120 million times in three days. 
There are grounds to believe that the Chinese Government became concerned 
that a perception that it was hiding something could cause panic and threaten 
its legitimacy. The growing agency of informed (or misinformed) consumers and 
citizens may be the truly big story of this episode. 
Responses to the problem of anti-microbial resistant organisms - as a key di-
mension of human-disease-ecology dynamics - is another illustration of the 
growing importance of global governance. Fidler (2003) argues that an effec-
tive anti-microbial is a global public good that needs to be preserved, drawing 
a parallel with ‘tragedy of the commons’ arguments in the environmental field 
(Hardin 1968) to argue that the incentives individuals face lead to unnecessary 
use and inappropriate dosages. He implies there may be a conflict between the 
right of access to treatment and the need to preserve anti-microbial efficacy. 
This raises challenging governance and  distributional issues, particularly in the 
context of pluralistic health systems that are poorly regulated in formal terms. 
It is interesting in this regard to consider the case of Malarone, an expensive 
combination of two anti-malarial drugs, whose high cost has helped preserve 
its efficacy. However this has been at the expense of social justice: those who 
can afford to buy it benefit at the expense of denying access to the poor. Similar 
issues may apply to pricing and regulation of second and third generation anti-
retroviral treatments of HIV. 
The networks involved in global health governance include a large and growing 
number of actors, such as large private corporations, non-government organi-
sations, advocacy groups, civil society organisations and large charitable foun-
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dations. One highly visible model is the so-called public private partnerships 
that have been constructed with mandates to address specific health problems, 
often with ambitious short-term targets for developing new technologies and 
spreading them rapidly around the world. These actors are establishing new 
forms of relationship with governments and with each other. This has led to a 
marked fluidity of institutional arrangements with rapidly changing relationships 
between states and a variety of local and international entities. As Kickbusch 
(2003) emphasises, there is often a strong political dimension to these. Powerful 
actors play a political role in the reshaping of global institutional arrangements, 
whether in the case of the pharmaceutical companies, or the likely influence of 
governments of economically powerful countries. 
Analysts writing from the perspective of historical institutionalism (Pierson 2000 
and 2003; Pierson and Skocpol 2002; Thelen 2003) argue that health sector in-
stitutions have developed in cycles of rapid change followed by long periods of 
consolidation. The dominant ideas, power relationships and available solutions 
to functional challenges at times of rapid change strongly influence subsequent 
development of institutions, which are highly path dependent. Such path de-
pendency reflects both political inertia and the high costs of implementing 
major institutional changes. It also reflects the key roles of power relations in the 
creation and maintenance of particular forms of health system (Bloom 2004c). 
On the one hand, such political and bureaucratic imperatives can sustain mana-
gerial approaches grounded in equilibrial ideas and assumptions, limiting ability 
to respond to dynamic health challenges. On the other hand, the proliferation of 
complex, globally networked institutional arrangements, partly as a response to 
such dynamics, suggests that we are entering a period of major reconfiguration. 
The fluidity of institutional arrangements opens up political spaces for reconfig-
uring governance arrangements for the future.  There are discursive dimensions 
to these emerging arrangements, as particular configurations of institutions/
power/knowledge about health problems are appearing across local and global 
scales, and sometimes contesting each other.
We should not expect the present situation, characterised by so much instabil-
ity, diverse forms of agency, and multiple responses to health challenges and 
uncertainties, to persist. One scenario is that change will take place in response 
to major public health crises. But what will future arrangements look like? How 
will they balance the need to respond to the complexity of challenges in a 
dynamic world, and the need for rapid and coherent responses? How will they 
win political legitimacy and manage power differentials? Will they move once 
more towards the kind of highly segmented system that protected the powerful 
from the diseases of the poor, as in the colonial period? Or can we envisage a 
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move towards governance arrangements for health that seek widespread legiti-
macy through a more inclusive and deliberative politics that gives voice to the 
needs and perspectives of all social groups, including the poor?
5. RESPONDING TO DYNAMIC HEALTH CHALLENGES: 
TOWARDS PATHWAYS TO SUSTAINABILITY
New understandings of the interaction between human ecology, technology and 
society highlight the mismatch between dominant models of health problems 
and responses, and the realities of complex systems dynamics. Indeed given the 
latter, using established intervention models may be wasteful and ineffective. 
They may even exacerbate the underlying processes themselves, or work against 
the interests of poorer and marginalised people. Also, fear of disasters has gen-
erated a search for simplistic solutions aimed largely at reducing the anxieties of 
the electorate in rich and powerful countries (Bourke 2005; Furedi 1997), often 
disregarding the impacts on poorer people. For instance given the nature of the 
amplifier mechanisms in long wave events, frameworks like scaling-up current 
standardised services may well prove ineffective.  Rather, what is needed are ap-
proaches that acknowledge dynamics, complexity and the diverse framings and 
goals of different groups, but that avoid policy paralysis arising from a sense that 
it is all too complicated. This entails thinking about scaling up in terms of am-
plifying diversity and adaptability of responses, as opposed to relying solely on 
enlarging or simply replicating standardised interventions.18 The final section of 
this paper explores elements of a research agenda towards possible approaches 
to addressing the health-related challenges that are likely to unfold amidst 
interacting socio-political, ecological and technological dynamics. It considers 
key questions for a STEPS agenda towards identifying pathways to Sustainability 
in relation to health.
18  In the case of HIV, the few attested prevention strategies, such as specific harm reduction 
and empowerment initiatives with groups key to the impact and to the transmission of the virus, 
came from close attention to the interactions between the virus and affected populations. In 
the case of arsenic poisoning in Bangladesh, the most viable responses seem to be multiple 
relatively local initiatives to manage affected water sources more effectively. These are approaches 
that emphasise adaptation and learning and in specific situations, in ways that incorporate the 
perspectives of those affected - as advocated in broader discussions of policy approaches in 
dynamic, uncertain situations (see STEPS Working Papers 1, 2 and 3 on Dynamics, Governance and 
Designs). 
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This is not the first time that human societies have coped with major health-
related challenges. One relevant comparison is the 19th Century experience of 
the first industrialised countries. These countries experienced rapid urbanisa-
tion, increased movements of people and goods and the emergence of new 
patterns of socio-economic inequality. Poor people in urban areas experienced 
high burdens of disease and limited life expectancy. A series of cholera epidem-
ics affected all social groups. Responses to the early outbreaks focused on in-
dividual survival and calls for divine assistance, but an understanding gradually 
emerged of cholera as a natural phenomenon that reflected failings in social 
organisation for public health (Williams 1987). Coalitions of scientists, health 
professionals, representatives of the growing middle class and, to some extent, 
the organised working class, eventually built a political consensus for action. 
This resulted in the establishment of several scientific disciplines and many of 
the institutional arrangements now conventionally associated with effective 
government, including the provision of safe water and the disposal of human 
wastes. It eventually led to the creation of modern health systems.
We are again experiencing rapid changes in patterns of settlement, of mobility 
and of  inequality and poverty on a global scale. This has been associated with 
a variety of health challenges (Szreter 1999). Coalitions for change are being 
constructed. We seem to be approaching a period of major reconfiguration of 
health systems. However, there are crucial differences from the 19th Century, 
many of which have been discussed in this paper. For instance:
• Elite groups in low and middle-income countries are largely protected 
from infection by water purification, immunisation and effective treat-
ments for many infections. They often live apart from the poor in 
'gated cities'. Their sense of security may impede the construction of 
political consensus for public health, although this may be countered 
by a growing sense of insecurity from globalised movements of people, 
animals and microbes.
• Population ageing, growth in the burden of chronic disease and devel-
opment of medical care technologies have created new expectations 
for treatment. Reforms to public health services could previously be 
linked to greater access to health care at modest cost. This is no longer 
possible, and governments and political movements face very difficult 
choices in negotiating rights to health care. The continuing develop-
ment of expensive new treatments for chronic diseases and the rapid 
spread of information about these treatments make these choices 
increasingly difficult.
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• The dramatic rise in education, in access to biomedical knowledge, 
and in popular and 'lay' framings makes the previous model, in which 
policies were determined by a few people in elite social groups and 
countries according to professionalised framings of health problems, 
implausible. People are less likely to accept the authority of top-down 
modes of government; there are greater demands for citizen voice; and 
governments need to earn legitimacy for taking public health actions.
• Networked forms of governance are emerging, yet complex patterns 
of power relations and inequality complicate coalition-building. For 
instance the legacy of post-colonial and post-revolutionary nation-
building and the international human rights framework has established 
expectations and nascent rights, which create challenges for the nego-
tiation of health policies that claim broad social legitimacy in the face of 
large structural inequalities.
• Developments in the media and in information technology have accel-
erated responses to challenges and to new therapeutic opportunities. 
They have increased the availability of diverse sources of information, 
and uncertainties, by which any given health intervention might be 
judged; they have made individual understandings and expectations 
increasingly important, but have also enhanced the possibility of panics 
and over-optimistic assessments of new therapies.19 This creates ex-
tremely difficult choices for policy-makers.
• Institutions have transformed a great deal over the past century, both 
shaped by and shaping dynamic socio-political and human-ecological 
relationships. The health sector now includes many hybrid forms of or-
ganisation, partnership and network, linking public and private across 
global and local scales. It is no longer useful to think of policy in terms 
of a dichotomy between ideal types of government bureaucracy and 
private entity.
• Global governance is decreasingly dominated by a few countries. The 
rise of new economic powers is challenging the stability of global ar-
rangements, as is the great importance of trans-national corporations, 
non-government organisations and private foundations. A variety of 
19  One example is the heavy media coverage of the potentially devastating impact of a pandemic 
of influenza or another infectious disease. This could lead to political pressure in the richer 
countries for measures aimed at reducing the fear of an uncertain future at the expense of a 
neglect of the more certain needs of the poor and powerless (Van Damme and Van Lerberge 2000; 
Bonneux and Van Damme 2006).
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citizen groupings at local, national and international levels asserts in-
creasing influence over government policies. Local and global media 
play an increasingly important role.
Given these transformations, we cannot expect a repetition, at the global level, 
of the 19th Century experience of state building for public health. Rather, there 
are now a number of contending scenarios for the development of responses 
to health challenges. These imply different relationships between institutions 
and social-ecological-technological dynamics, and imply different pathways. 
Some may lead to Sustainability, others may not; while they have divergent im-
plications for meeting Sustainability goals as framed and valued by poorer and 
marginalised people. Thus we could be entering a period of reconstruction of 
state capacity and the emergence of national and global public health systems 
organised and financed by governments supported by large financial flows to 
low-income countries. Alternatively, we may experience the further growth 
and consolidation of structural inequalities and the emergence of so-called 
‘apartheid’ or ‘gated city’ models of public health, implying resilience against 
epidemics at a national or global level, but at the costs of social injustice. This 
would imply certain populations enjoying high levels of health-related services, 
while others receive minimum services. It would be associated with a ‘city-state’ 
model of global development with centres of formally-organised economic 
and social activities surrounded by areas of deprivation where informal regula-
tions prevail. The development of an illicit market for body parts for transplant 
operations illustrates the kinds of unequal valuation of wellbeing and even life 
that this model of development could institutionalise. As a third scenario, at a 
global level international health governance may become reconfigured around 
a dominant consensus on critical global and local health threats linked to un-
derstandings of dynamic systems, and ways of responding to them in adaptive 
ways that address the priorities of the poor. On the other hand, global gover-
nance may also be captured by corporate and contending multilateral interests 
such as international trade bodies.
The changing landscape of knowledge and power in relation to health also 
suggests alternative scenarios. For instance, the growth of information tech-
nology could lead to quite new ways of organising medical care. For example, 
the linkages between people with specific diseases and vertically integrated 
pharmaceutical/service delivery companies could strengthen, fostering models 
of managed life-time care but with a potential for a problematic ‘medicalisation’ 
of chronic conditions that entraps poorer people in heavy treatment expenses 
while denying alternative approaches for dealing with disease. Alternatively, 
horizontal coalitions of informed citizens could emerge that press for govern-
ment action to enhance equity and create regulatory arrangements for highly 
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devolved health systems in which very different, more reflexive and delibera-
tive relationships between state, market and civil society organisations become 
established. 
It is unlikely that any one of these, or indeed other, imaginable models will 
dominate global systems in the foreseeable future and some may co-exist and 
influence each other. The plausibility of each scenario highlights the fluidity of 
present arrangements and the likelihood that the outcome will be determined by 
the forms that responses to new challenges take. The health work of the STEPS 
Centre aims to promote debate and reflexivity concerning the ways different 
perspectives on systems dynamics and governance arrangements co-evolve, 
and their implications for poverty reduction and social justice. Centrally, we aim 
to contribute to the development of institutional arrangements that give voice 
to the concerns of the poor in this dynamic world. Such arrangements need to 
be designed to promote pathways to Sustainability, in the sense of promoting 
and maintaining system structures and functions important to poorer people, 
and enhancing resilience and robustness in the face of shocks and stresses. 
To move towards this goal in turn requires research approaches that attend to 
several key sets of issues.
RESPONDING TO COMPLEX, DYNAMIC DISEASE ECOLOGIES
We need to know more about the inter-relationships between social, techno-
logical and ecological dynamics in the generation of health challenges and 
responses to them, taking account of non-linear dynamics and path dependen-
cies across multiple scales. This involves the identification of strategies that deal 
effectively with the interactive and cumulative effects of shocks, stresses and 
long wave events, that build resilience and that help individuals and societies 
escape from low efficiency, low health status vicious circles. It also involves the 
use of understandings of dynamics to identify potential unintended outcomes 
of specific interventions, an acknowledgement of the great uncertainty that 
adheres to many health-related decisions and the construction of adaptive and 
reflexive approaches for responding to them.
RECONFIGURING GOVERNANCE FOR AN UNCERTAIN WORLD
We need new understandings of and approaches to health governance that 
recognise interactions of multiple institutions, actors and networks, and that take 
into account the political economy of social arrangements and of knowledge 
in framing and responding to health problems. This involves recognising and 
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responding to a range of changing realities. As the role of individuals and citizen 
groups in responding to health challenges increases, we need to understand 
how they gain access to different forms of health knowledge, assess their 
reliability and act. For instance, a decision to provide countries with large 
quantities of drugs should be complemented by measures to support informed 
citizenship through dialogic approaches and to build regulatory partnerships 
to reduce the risk of exposure to sub-standard drugs and of the development 
of treatment-resistant organisms. Equally, as health systems undergo change 
involving a variety of actors, networks and other entities, we need to understand 
how legitimated institutional arrangements and intervention designs can 
be produced in the face of different framings of health challenges, and what 
strategies might best address divergent and conflicting goals. The construction 
of languages that enable and legitimate shared rules and social norms; 
deliberative and reflexive approaches to governance; and appraisal designs 
that aim to open up the range of perspectives included and to broaden out 
the range of options for policy, all offer potential ways forward of relevance to 
addressing health challenges (see STEPS Working Papers 2 and 3 on Governance 
and Designs). Developing and applying these in settings of extreme inequality 
nevertheless poses enormous challenges. Especially in settings where powerful 
actors seek to influence governance arrangements in their own interest, it is 
crucial to explore the potential both of deliberative approaches, and of other 
types of collective responses that can counterbalance this. 
CONSTRUCTING PATHWAYS TO SUSTAINABILITY IN DIVERSE CONTEXTS
Both the dynamics of human-disease-ecological systems and governance 
arrangements, and the framings and understandings that underpin them, 
emerge in particular ways in particular places. They have specific histories and 
socio-political contexts that influence both present patterns and pathways to 
future change. Current arrangements both reflect the experience and institu-
tional constructions of the past, in path-dependent ways shaped by political 
history and culture, and respond to new challenges, patterns of inequality and 
technological opportunities. As an alternative to approaches that assume that 
dominant models can be unproblematically transferred, scaled up and rolled 
out, we need to address how such standard approaches are reinterpreted and 
acquire new meanings in particular contexts. We need to address how alterna-
tive responses to specific health challenges can be constructed in ways rooted 
in and appropriate to diverse contexts, and how this can help build pathways to 
Sustainability in health that address the perspectives and priorities of those with 
little economic and political power. 
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It is by integrating such concerns with dynamics and governance through a lens 
that gives weight to the specificity of particular places and their histories, that 
the STEPS Centre is developing a ‘pathways approach’ to health issues. As this 
paper has argued, today’s world is characterised by dynamics - in intertwined 
ecological, social and technological systems - that are posing major new health 
challenges. The mismatch between these and the assumptions of mainstream, 
historically-embedded policy and management approaches are becoming more 
evident than ever, contributing to situations that compromise sustainability and 
the interests of the poor. Turning these tendencies around, while making the 
most of the opportunities for health advances represented by current global 
interest and rapid technological advance, will require some major rethinking 
and reworking - in understandings of the systems that affect health, and of gov-
ernance arrangements that can respond to them effectively. Only in this way 
can we envisage the construction of pathways to Sustainability that can ensure 
resilience amidst the health challenges of the 21st century in ways that simulta-
neously enhance poverty reduction and social justice. 
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